From left to right, up and down, Joan Comella and Josep A. Planell, Ángel Raya, José Antonio del Río, Miquel Vila and Manuel Galiñanes
Vall d'Hebron Reserach Institute (VHIR) and the Institute for Bioengineering of Catalonia (IBEC) have signed today an agreement of collaboration for the joint development of research and innovation projects.
This agreement, signed by the directors of both institutions, Joan Comella (VHIR) and Josep A. Planell (IBEC), will cover the shared development of sanitary innovative interventions, activities of technology and knowledge transfer. In addition, it will help the exchange of scientific and technical staff, organization of seminars and scientific and social events, and to establish preferential conditions for the use of the respective equipments.
Both institutes will take advantage of the existing synergies in the frame of their respective activities, will promote studies and joint projects in the area of biomedicine and will generate technological and scientific opportunities for the application in priority areas of scientific collaboration.
According to VHIR's director, Joan Comella, the agreement "is an opportunity to collaborate with a leading institute in bioengineering and nanomedicine and it will strengthen both institutions". IBEC's director, Josep A. Planell, thinks that this agreement means "consolidating the collaboration of IBEC with the research institute of one of the most important hospitals of the country. This is a decisive step in the strategy to transfer the results of our research to the patient ".
To begin this collaboration there has been a meetting at VHIR between researchers from both institutes. Representatives of the different research groups have explained the projects in which are already collaborating.
These have been the researchers who participated in the first meeting VHIR-IBEC (VIDEOS). From VHIR, Dr. Miquel Vila, head of the neurodegenerative diseases group, and Dr. Manuel Galiñanes, head of the reparative therapy of the heart group. From IBEC, Dr. Ángel Raya, head of the Control of Control of the power of the stem cells, and Dr. José Antonio del Río, head of the cellular and molecular neurobiotecnology.
Agreement of collaboration video
VHIR in the media: La Vanguardia, Qué!, El Economista, La Información